State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?

Chimeric antigen receptor (CAR)-T cell therapy has proven to be a powerful treatment for hematological malignancies. The situation is very different in the case of solid tumors, for which no CAR-T-based therapy has yet been approved. There are many factors contributing to the absence of response in...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Beatriz Amorós-Pérez, Benigno Rivas-Pardo, Manuel Gómez del Moral, José Luis Subiza, Eduardo Martínez-Naves
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	cancer immunotherapy chimeric antigen receptors CAR-T cells solid tumors
Online Access:	https://www.mdpi.com/2073-4409/13/9/725